Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) Stock

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF), operating with its various subsidiaries, is a diversified pharmaceutical conglomerate primarily engaged in the research, development, manufacturing, and global distribution of a broad spectrum of medical products. This includes traditional Chinese patented medicines, Western pharmaceuticals, chemical raw materials, natural and biological medicines, as well as chemical raw material intermediates. The company's reach extends throughout the People's Republic of China and into international markets. Its operations are strategically divided into four primary segments: Great Southern TCM, Great Commerce, Great Health, and an 'Others' category. Beyond its core pharmaceutical activities, GZPHF also handles the wholesale, retail, import, and export of both Western and Chinese medicines, alongside medical apparatus and instruments. Furthermore, the company is involved in the innovation, production, and sale of a diverse range of consumer goods such as beverages, food items, health supplements, pre-packaged foods, dairy products, and various pharmaceutical forms including tablets, capsules, lozenges, and injections, even extending to traditional tortoise herb jelly. Additionally, the company strategically invests in the broader health industry, encompassing areas like medical services, health management, wellness and preservation, and elderly care. It also provides commercial and advertising services. As of December 31, 2021, GZPHF maintained a significant retail presence with 154 chain pharmacy outlets. These comprised 22 Cai Zhi Lin pharmacy locations, 36 Jian Min pharmacy outlets, 51 GPC Prescription Pharmacy stores, and 23 Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd. outlets. Complementing these, the company also operated 22 general retail stores. The enterprise, headquartered in Guangzhou, China, was established in 1997. It was formerly known as Guangzhou Pharmaceutical Company Limited before officially adopting its current name, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, in August 2013.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is headquartered in CN.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) stock trades at $2.34 with a market capitalization of $6.20B. The stock is valued at a price-to-earnings (P/E) ratio of 12.06, price-to-book of 0.90, price-to-sales of 0.45. Over the past 52 weeks the stock has ranged between $2.14 and $2.88, and currently trades 18.8% below its 52-week high. It pays a dividend yielding 5.56%.

On profitability, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited generates a return on equity (ROE) of 7.70%, return on capital employed of 6.62%, an operating margin of 4.13%, a net profit margin of 3.75%.

Official website: www.gybys.com.cn